Compare NSIT & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NSIT | MIR |
|---|---|---|
| Founded | 1988 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Industrial Machinery/Components |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 3.9B |
| IPO Year | 1996 | 2020 |
| Metric | NSIT | MIR |
|---|---|---|
| Price | $155.23 | $14.26 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | ★ $116.25 | $27.25 |
| AVG Volume (30 Days) | 282.9K | ★ 3.2M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 161.11 |
| EPS | ★ 3.53 | 0.02 |
| Revenue | ★ $8,247,180,000.00 | N/A |
| Revenue This Year | $3.79 | $23.95 |
| Revenue Next Year | $2.16 | $7.32 |
| P/E Ratio | ★ $43.88 | $713.25 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $63.62 | $14.11 |
| 52 Week High | $168.50 | $30.28 |
| Indicator | NSIT | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 50.34 | 36.79 |
| Support Level | $151.82 | $14.17 |
| Resistance Level | $157.35 | $16.38 |
| Average True Range (ATR) | 6.27 | 0.65 |
| MACD | -1.22 | -0.19 |
| Stochastic Oscillator | 18.40 | 0.62 |
Insight Enterprises Inc is a Fortune IT provider engaged in helping businesses of all sizes, large enterprises, government agencies, schools, and healthcare organizations. The company has three geographic operating segments: North America, EMEA, and APAC. It generates maximum revenue from the North America segment. The company provides digital workplace, cloud/data center transformation, IT modernization, Cyber Security and supply chain optimization solutions and services.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.